Nina Weisser

Nina Weisser

Company: Zymeworks

Job title: Director - Multispecific Antibody Therapeutics

Seminars:

Using Trispecific T-Cell Engagers Alongside Checkpoint Inhibition to Enhance the Therapeutic Applications of TCEs 3:15 pm

Combining trispecific T-cell engagers with checkpoint inhibition to simultaneously target tumor cells, activate T-cells, and block immune suppressive pathways, enhancing antitumor immunity Optimizing trispecific T-cell engager design to improve tumor specificity, T-cell recruitment, and immune checkpoint blockade for synergistic therapeutic effects Exploring the clinical potential of trispecific engagers with checkpoint inhibitors in solid and hematologic…Read more

day: Day 2

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.